Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 1552-1554, 2003; 10.1373/49.9.1552
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prontera, C.
Right arrow Articles by Clerico, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prontera, C.
Right arrow Articles by Clerico, A.
Related Collections
Right arrow Heart Health and the Clinical Laboratory
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2003;49:1552-1554.)
© 2003 American Association for Clinical Chemistry, Inc.

Letters to the Editor

Natriuretic Peptides (NPs): Automated Electrochemiluminescent Immunoassay for N-Terminal pro-BNP Compared with IRMAs for ANP and BNP in Heart Failure Patients and Healthy Individuals

Concetta Prontera1, Michele Emdin1, Gian Carlo Zucchelli1, Andrea Ripoli1, Claudio Passino1 and Aldo Clerico1,a

1 Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche, Località San Cataldo, Via Moruzzi, 1, 56100 Pisa, Italy

aAuthor for correspondence. Fax 39-050-3152116 or 39-0585-493601; e-mail clerico@ifc.cnr.it.

The first 20% of the full text of this article appears below.


To the Editor:

We evaluated the performance and diagnostic accuracy of an electrochemiluminescence immunoassay (ECLIA) method for N-terminal pro-B-type natriuretic peptide (NT-proBNP) in healthy persons and in patients with cardiac disease, and then compared the results obtained with the ECLIA method with results from IRMA methods for BNP and atrial natriuretic peptide (ANP).

We studied 58 healthy individuals [mean (SD) age, 58 (8) years; 19 women and 39 men] and 148 consecutive patients [mean age, 64 (13) years; range, 20–80 years; 47 women and 101 men] with cardiomyopathy, admitted to the Department of Cardiovascular Medicine of our Institute. The study was done from November 2001 to October 2002. All healthy participants were nonobese, normotensive, and free from acute diseases, and all denied the use of any drug during the 4 weeks before the study. All had normal values for the main plasma indices and nonpathologic erythrocyte and leukocyte counts and urine analysis. In all of the participants, a complete cardiologic examination, including electrocardiogram and echocardiographic investigation (left ventricular ejection fraction >55%), was performed; in patients >50 years of age, an effort stress test was performed . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
C. Vassalle, M. G. Andreassi, C. Prontera, M. Fontana, L. Zyw, C. Passino, and M. Emdin
Influence of ScaI and Natriuretic Peptide (NP) Clearance Receptor Polymorphisms of the NP System on NP Concentration in Chronic Heart Failure
Clin. Chem., November 1, 2007; 53(11): 1886 - 1890.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Mueller, A. Gegenhuber, B. Dieplinger, W. Poelz, and M. Haltmayer
Capability of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP as Indicators of Cardiac Structural Disease in Asymptomatic Patients with Systemic Arterial Hypertension
Clin. Chem., December 1, 2005; 51(12): 2245 - 2251.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Clerico, C. Prontera, M. Emdin, C. Passino, S. Storti, R. Poletti, L. Zyw, and G. C. Zucchelli
Analytical Performance and Diagnostic Accuracy of Immunometric Assays for the Measurement of Plasma B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP
Clin. Chem., February 1, 2005; 51(2): 445 - 447.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Hammerer-Lercher, W. Ludwig, G. Falkensammer, S. Muller, E. Neubauer, B. Puschendorf, O. Pachinger, and J. Mair
Natriuretic Peptides as Markers of Mild Forms of Left Ventricular Dysfunction: Effects of Assays on Diagnostic Performance of Markers
Clin. Chem., July 1, 2004; 50(7): 1174 - 1183.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Clerico and M. Emdin
Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A Review
Clin. Chem., January 1, 2004; 50(1): 33 - 50.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.